TABLE 2.
Patient Characteristics.
| Control Group (n = 86) | Intervention Group (n = 82) | p | |
|---|---|---|---|
| Sex n, (%) | >0.05 | ||
| Female | 28, (32.56%) | 43, (52.44%) | |
| Male | 58, (67.44%) | 39, (47.56%) | |
| BMI (Median [IQR]) | 25.95, [23.43–28.07] | 25.20, [23.40–27.70] | >0.05 |
| Weight (kg) | 75, [70–80] | 71, [65–80] | |
| Height (m) | 1.7, [1.66–1.74] | 1.67, [1.6–1.75] | |
| Age (mean ± SD) | 72.19 ± 12.73 | 68.80 ± 16.30 | >0.05 |
| No of Comorbidities (mean ± SD) | 3.71 ± 1.74 | 3.66 ± 1.67 | >0.05 |
| 1 (n, %) | 6, (6.98%) | 9, (10.97%) | |
| 2 (n, %) | 18, (20.93%) | 14, (17.07%) | |
| 3 (n, %) | 22, (25.58%) | 16, (19.51%) | |
| 4 (n, %) | 11, (12.79%) | 17, (20.73%) | |
| 5 (n, %) | 16, (18.60%) | 12, (14.63%) | |
| 6 (n, %) | 6, (6.98%) | 11, (13.41%) | |
| 7 (n, %) | 5, (5.81%) | 3, (3.65%) | |
| 8 (n, %) | 2, (2.33%) | – | |
| Most common 10 Comorbidities (n, %) | N.A. | ||
| Hypertension | 42, (48.84%) | 49, (59.75%) | |
| Coronary Artery Disease | 35, (40.70%) | 27, (32.93%) | |
| Chronic obstructive pulmonary disease | 31, (36.05%) | 32, (39.02%) | |
| Type 2 Diabetes Mellitus | 27, (31.40%) | 21, (25.61%) | |
| Pulmonary Embolism | 24, (27.91%) | 13, (15.85%) | |
| Cancer | 22, (25.58%) | 14, (17.07%) | |
| Asthma | 12, (13.95%) | 11, (13.41%) | |
| Atrial Fibrillation | 12, (13.95%) | 4, (7.87%) | |
| Kidney failure | 12, (13.95%) | 14, (17.07%) | |
| Length of Hospital Stay (day) (mean ± SD) | 11.57 ± 8.56 | 9.72 ± 6.08 | p > 0.05 |
| <10 (n, %) | 44, (51.16%) | 51, (62.20%) | |
| 10-19 (n, %) | 28, (32.56%) | 26, (31.71%) | |
| 20-30 (n, %) | 9, (10.46%) | 4, (4.88%) | |
| >30 (n, %) | 5, (5.82%) | 1, (1.12%) | |
| Number of Drugs per patient (mean ± SD) | 14.45 ± 7.59 | 15.5 ± 6.18 | p > 0.05 |
| Charlson Comorbidity Index (CCI) (Median, [IQR]) | 5, [3–7] | 4, [3–6] | p > 0.05 |